The ROE as of September 2024 (TTM) for Akebia Therapeutics, Inc. (AKBA) is 123.47%

According to Akebia Therapeutics, Inc.’s latest financial reports and current stock price. The company's current ROE is 123.47%. This represents a change of 291.50% compared to the average of 31.54% of the last 4 quarters.

Akebia Therapeutics, Inc. (AKBA) Historical ROE (quarterly & annually)

How has AKBA ROE performed in the past?

The mean historical ROE of Akebia Therapeutics, Inc. over the last ten years is -187.01%. The current 123.47% ROE has changed -166.02% with respect to the historical average. Over the past ten years (40 quarters), AKBA's ROE was at its highest in in the March 2023 quarter at 116.62%. The ROE was at its lowest in in the September 2022 quarter at -402.34%.

Akebia Therapeutics, Inc. (AKBA) ROE by Quarter and Year

Discovering the peaks and valleys of Akebia Therapeutics, Inc. ROE, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Akebia Therapeutics, Inc. (AKBA) Average ROE

How has AKBA ROE performed in the past?

The current ROE of Akebia Therapeutics, Inc. (AKBA) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages

Akebia Therapeutics, Inc. (AKBA) ROE vs. Peers

How is AKBA’s ROE compared to its peers?

Akebia Therapeutics, Inc.’s ROE is greater than Protalix BioTherapeutics, Inc. (-45.15%), greater than Cidara Therapeutics, Inc. (-401.89%), less than X4 Pharmaceuticals, Inc. (32.93%), less than Seres Therapeutics, Inc. (313.56%), less than AVROBIO, Inc. (29.68%), greater than CohBar, Inc. (-55.32%), less than Ocean Biomedical, Inc. (567.07%), greater than Enveric Biosciences, Inc. (-234.16%), greater than Elevation Oncology, Inc. (-57.97%), greater than Hepion Pharmaceuticals, Inc. (-328.66%),

Build a custom stock screener for Akebia Therapeutics, Inc. (AKBA) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Akebia Therapeutics, Inc. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Akebia Therapeutics, Inc. (AKBA) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Akebia Therapeutics, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.